Canada markets closed

Syros Pharmaceuticals, Inc. (0S9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7412-0.0014 (-0.19%)
At close: 08:08AM CEST
Show:
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
23,488
23,488
15,093
1,982
2,050
Operating Expenses
Research Development
99,872
99,872
76,065
58,245
50,182
Selling General and Administrative
23,036
23,036
21,325
21,478
16,164
Total Operating Expenses
122,908
122,908
97,390
79,723
66,346
Operating Income or Loss
-99,420
-99,420
-82,297
-77,741
-64,296
Interest Expense
3,907
3,907
1,792
-
-
Total Other Income/Expenses Net
16,682
16,682
-375
2,303
2,017
Income Before Tax
-86,558
-86,558
-84,038
-75,438
-62,279
Income from Continuing Operations
-86,558
-86,558
-84,038
-75,438
-62,279
Net Income
-86,558
-86,558
-84,038
-75,438
-62,279
Net Income available to common shareholders
-86,558
-86,558
-84,038
-75,438
-62,279
Basic EPS
-
-
-1.82
-1.88
-1.91
Diluted EPS
-
-
-1.82
-1.88
-1.91
Basic Average Shares
-
-
46,052
40,222
32,656
Diluted Average Shares
-
-
46,052
40,222
32,656
EBITDA
-
-79,633
-79,211
-75,019
-62,692